# Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease

> **NCT02057016** · — · COMPLETED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 258 (actual)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02057016
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2015-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057016, "Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02057016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*